ALNYLAM PHARMACEUTICALS, INC.;LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.
发明人:
Dinah Sah,Pamela Tan,Webster Cavenee,Frank Furnari,Maria del Mar Inda Perez,Rudy Bonavia
申请号：
US14936059
公开号：
US09957507B2
申请日:
2015.11.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a mutant Epidermal Growth Factor Receptor (EGFR), and methods of using the dsRNA to inhibit expression of mutant EGFR.
